5Fassina G, Vene R. Morini M, et al. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clin Cancer Res, 2004, 10:4865-4873.
6Singh D, Chander V, Chopra K. Protective effect of catechin on ischemia- reperfusion-induced renal injury in rats. Pharmacol Rep,2005,57:70-76.
7Blanco AR, La Terra Mule S, Babini G, et al. (-)epigallocatechin-3-gallate inhibits gelatinase activity of some bacterial isolates fromocular infection, and limits their invasion through gelatine. Biophys Acta, 2003,1620:273-281.
8Crespy V, Morand C, Besson C, et al, The splanchnic metabolism of flavonoids highly differed according to the nature of the compound. Am J Physiol Gastrointest Liver Physiol, 2003,284: 980-988.
9Suzuki H, Yamamoto S, Hirayama C, et al. Cianidanol therapy for HBe antigen-positive chronic hepatitis: a multieentre, double-blind study. Liver, 1986,6 : 35-44.
